Burkina Faso vs Japan: The number of people with susceptibility test result for rifampicin
Burkina Faso
67.26
in 2021
Japan
62.2
in 2021
Burkina Faso rank
106th
Japan rank
108th
The number of people with susceptibility test result for rifampicin over time
- Burkina Faso
- Japan
How they compare
Burkina Faso currently reports 67.26 against 62.2 in Japan, a difference of 5.06.
That makes Burkina Faso's figure about 1.1 times Japan's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Japan ahead.
Burkina Faso ranks 106th and Japan ranks 108th of 146 countries.
Across the 2 decades both report, Burkina Faso averaged higher in 1 and Japan in 1.
Head to head by decade
| Decade | Burkina Faso | Japan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 35.04 | 71.84 | 36.8 | Japan |
| 2020s | 78.72 | 63.07 | 15.66 | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Burkina Faso or Japan?
- Burkina Faso, at 67.26 against 62.2 in Japan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Burkina Faso and Japan?
- 5.06, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Japan?
- 5 years are reported by both, from 2017 to 2021.
- How do Burkina Faso and Japan rank globally for the number of people with susceptibility test result for rifampicin?
- Burkina Faso ranks 106th and Japan ranks 108th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.